📊 TDOC Key Takeaways
Is Teladoc Health, Inc. (TDOC) a Good Investment?
Teladoc operates at a significant loss with declining revenue and extremely low gross margins (13.7%), indicating fundamental operational challenges in its business model. While the company maintains a fortress balance sheet with $750.7M cash and minimal debt, these reserves are being gradually consumed, providing limited runway for operational turnaround without rapid margin expansion.
Teladoc Health, Inc. Key Strengths (TDOC)
- Strong balance sheet with $750.7M cash and minimal leverage (0.03x debt/equity)
- Healthy liquidity ratios (2.80x current, 2.72x quick) providing operational flexibility
- Improved EPS by 80.6% YoY suggesting cost reduction initiatives underway
TDOC Stock Risks: Teladoc Health, Inc. Investment Risks
- Persistent operating losses (-$61.8M) with contracting revenue (-1.5% YoY)
- Critically low gross margin (13.7%) indicates structural unit economics problems or severe pricing pressure
- Barely positive free cash flow ($7.9M or 1.3% FCF margin) is unsustainable given revenue base
- Negative returns on equity (-4.8%) and assets (-2.3%) destroying shareholder value
Key Metrics to Watch
- Gross margin expansion trajectory - must reach 25%+ for profitability pathway
- Revenue stabilization and return to growth
- Operating cash flow acceleration and path to positive operating income
Teladoc Health, Inc. (TDOC) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The relatively thin 1.3% FCF margin may limit capital allocation flexibility. Strong liquidity with a 2.80x current ratio provides a solid financial cushion.
TDOC Profit Margin, ROE & Profitability Analysis
TDOC vs Services Sector: How Teladoc Health, Inc. Compares
How Teladoc Health, Inc. compares to Services sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Teladoc Health, Inc. Stock Overvalued? TDOC Valuation Analysis 2026
Based on fundamental analysis, Teladoc Health, Inc. has mixed fundamental signals relative to the Services sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Teladoc Health, Inc. Balance Sheet: TDOC Debt, Cash & Liquidity
TDOC Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Teladoc Health, Inc.'s revenue has shown modest growth of 8% over the 5-year period. The most recent EPS of $-1.34 indicates the company is currently unprofitable.
TDOC Revenue Growth, EPS Growth & YoY Performance
TDOC Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $613.8M | -$63.8M | $-0.36 |
| Q3 2025 | $626.4M | -$33.3M | $-0.19 |
| Q2 2025 | $631.9M | -$32.7M | $-0.19 |
| Q1 2025 | $629.4M | -$81.9M | $-0.49 |
| Q3 2024 | $640.5M | -$33.3M | $-0.19 |
| Q2 2024 | $642.4M | -$65.2M | $-0.40 |
| Q1 2024 | $629.2M | -$69.2M | $-0.42 |
| Q3 2023 | $611.4M | -$57.1M | $-0.35 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Teladoc Health, Inc. Dividends, Buybacks & Capital Allocation
TDOC SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Teladoc Health, Inc. (CIK: 0001477449)
📋 Recent SEC Filings
| Date | Form | Document | Action |
|---|---|---|---|
| May 21, 2026 | 4 | xslF345X06/wk-form4_1779398065.xml | View → |
| May 21, 2026 | 4 | xslF345X06/wk-form4_1779398044.xml | View → |
| May 21, 2026 | 4 | xslF345X06/wk-form4_1779398027.xml | View → |
| May 21, 2026 | 4 | xslF345X06/wk-form4_1779398014.xml | View → |
| May 21, 2026 | 4 | xslF345X06/wk-form4_1779397989.xml | View → |
❓ Frequently Asked Questions about TDOC
What is the AI rating for TDOC?
Teladoc Health, Inc. (TDOC) has an AI grade of C with 82% confidence, based on fundamental analysis of SEC EDGAR filings.
What are TDOC's key strengths?
Claude: Strong balance sheet with $750.7M cash and minimal leverage (0.03x debt/equity). Healthy liquidity ratios (2.80x current, 2.72x quick) providing operational flexibility.
What are the risks of investing in TDOC?
Claude: Persistent operating losses (-$61.8M) with contracting revenue (-1.5% YoY). Critically low gross margin (13.7%) indicates structural unit economics problems or severe pricing pressure.
What is TDOC's revenue and growth?
Teladoc Health, Inc. reported revenue of $613.8M.
Does TDOC pay dividends?
Teladoc Health, Inc. does not currently pay dividends.
Where can I find TDOC SEC filings?
Official SEC filings for Teladoc Health, Inc. (CIK: 0001477449) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is TDOC's EPS?
Teladoc Health, Inc. has a diluted EPS of $-0.36.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is TDOC's fundamental grade?
Based on our AI fundamental analysis in June 2026, Teladoc Health, Inc. has a C grade with 82% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is TDOC stock overvalued or undervalued?
Valuation metrics for TDOC: ROE of -4.8% (sector avg: 16%), net margin of -10.4% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
What is TDOC's AI grade for 2026?
Our dual AI analysis gives Teladoc Health, Inc. a combined C grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is TDOC's free cash flow?
Teladoc Health, Inc.'s operating cash flow is $9.5M, with capital expenditures of $1.7M. FCF margin is 1.3%.
How does TDOC compare to other Services stocks?
Vs Services sector averages: Net margin -10.4% (avg: 10%), ROE -4.8% (avg: 16%), current ratio 2.80 (avg: 1.5).